CClinicalTrials.gg
CompletedNCT01239784Updated Aug 27, 2013

Neurodevelopmental Rehabilitation for Toddlers With Complex Heart Defects

A Phase 2 interventional study of Home-based neurodevelopmental rehabilitation programme in Heart Defects, sponsored by The Hospital for Sick Children. Completed at 1 site in Canada. Open to participants aged 12 Months to 24 Months. Per ClinicalTrials.gov, last updated 2013-08-27.

Sponsored by The Hospital for Sick Children · Phase 2, Interventional, and Supportive care

Phase
Phase 2
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
12 Months to 24 Months
Sex
All
01

Study summary

The purpose of this project is to investigate the feasibility of using a home-based, parent-delivered model for providing neurodevelopmental rehabilitation programmes to infants who have had surgery for a complex heart defect.

Read the detailed description

Neurodevelopmental deficits are a common morbidity among children who receive surgical treatment for complex congenital heart defects in infancy. Over 40% of children with complex heart defects will have neurodevelopmental deficits that persist throughout childhood even after a successful surgical procedure in infancy1. These deficits are typically related to basic motor perceptual motor or visual motor skills. Problems integrating what is seen (visual perceptions) with body movement (motor skills) makes it difficult for children to participate in peer play and limits their ability to succeed in school, thereby having a significant impact on the child's quality of life.

Traditional, therapist-delivered rehabilitation programmes to address these delays in neurodevelopment have not previously been attempted. It would be difficult to provide direct rehabilitation programmes to these patients given that their defects are rare and few patients are located within the same geographical area. Home-based, parent-delivered rehabilitation programmes have previously been shown to be effective at improving the motor skills of school-age children with complex heart defects5. Since a home-based parent delivered model would enable the participation of infants regardless of geographic location, the feasibility of using such a model for delivering neurodevelopmental rehabilitation should be investigated.

02

Conditions studied

  • Heart Defects

Keywords

  • pediatrics
  • Heart Defects
  • Neurodevelopmental deficit
  • Neurodevelopmental Rehabilitation
03

In context

Lead sponsor

The Hospital for Sick Children is the lead sponsor of 568 studies on the registry; 81 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Months to 24 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Families will be eligible to participate in this study if the child:

  • Had the arterial switch operation (for transposition of the great arteries) or has had a Glenn procedure (for functional single ventricle).
  • Is medically stable for normal infant activities.
  • Is between 12 and 24 months of age in January 2010.

Exclusion criteria

Exclusion Criteria:

Families will be excluded from study participation if:

  • The child has a recognized syndrome or other disability affecting neurodevelopment.
  • The child has had a medical procedure in the 3 months preceding the baseline study assessment.
  • The cardiologist responsible for the child's care refuses to allow the child's participation.
  • The child performs substantially above age-appropriate developmental milestones during the initial assessment (in which case an intervention is unlikely to have a detectable additional benefit).
05

Study design

Phase
Phase 2
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    All Subjects

    A total of 20 children and their parents will be recruited for this study. Ten children will have had the Glenn procedure and 10 infants will have had the arterial switch operation.

    Behavioral: Home-based neurodevelopmental rehabilitation programme

Interventions

  • BehavioralHome-based neurodevelopmental rehabilitation programme

    Participation in the study will require the parent and child to attend two assessment visits in addition to completing a series of parent and infant activities on a daily basis throughout the 10-week intervention period. The parent-led activities will include activities such as walking with the child, stacking blocks, rolling a ball to the child, hiding a toy under a blanket for the child to find, encouraging the child to kick a rattle while the child is lying on his/her back, or crawling or rolling in different directions.

06

What researchers measure

Primary outcomes

  1. Change from baseline in child's neurodevelopmental status at four months using the Peabody Development Motor Scales

    The Peabody Development Motor Scale has demonstrated validity and reliability for children from birth to 5 years of age. Six subtests (reflexes, stationary, locomotion, object manipulation, grasping, visual-motor integration) yield gross, fine and total motor quotient scores.

    Time frame: Baseline and four months

Secondary outcomes

  1. Parents opinion on the home-based neurodevelopmental rehabilitation programme

    During the final assessment, the researcher will interview the parent to obtain their perspective on delivering the study activities at home.

    Time frame: at 4 months

  2. Research students experience and perception of guiding a home-based, parent-delivered rehabilitation programme

    Research students participating in this project will also be interviewed regarding their experiences and perceptions of guiding a home-based, parent-delivered rehabilitation programme.

    Time frame: at 4 months

07

Study locations

1 site
  • The Hospital for Sick Children
    Toronto, Ontario M5G 1X8, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01239784
Lead sponsor
The Hospital for Sick Children
Responsible party
Brian McCrindle (Staff Cardiologist, The Hospital for Sick Children) — Principal investigator
First posted
Nov 11, 2010
Start date
Oct 2009
Primary completion
Jun 2010
Completion
Jun 2010
Last update
Aug 27, 2013

Study contacts

Brian McCrindle, MD
principal investigator · The Hospital for Sick Children, Toronto Canada

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion